Outlook Therapeutics
OTLK
#9570
Rank
โ‚ฌ33.4 M
Marketcap
1,41ย โ‚ฌ
Share price
3.52%
Change (1 day)
-82.54%
Change (1 year)

Earnings for Outlook Therapeutics (OTLK)

Earnings in 2024 (TTM): -โ‚ฌ86.78 Million

According to Outlook Therapeutics 's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -โ‚ฌ49.47 Million, an increase over its 2022 earnings that were of -โ‚ฌ67.49 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Outlook Therapeutics from 2015 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -โ‚ฌ86.78 Million75.43%
2023 -โ‚ฌ49.47 Million-26.7%
2022 -โ‚ฌ67.49 Million32.13%
2021 -โ‚ฌ51.08 Million46.21%
2020 -โ‚ฌ34.94 Million-18.82%
2019 -โ‚ฌ43.04 Million16.62%
2018 -โ‚ฌ36.9 Million57.88%
2017 -โ‚ฌ23.38 Million-56.17%
2016 -โ‚ฌ53.33 Million-9.26%
2015 -โ‚ฌ58.77 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-โ‚ฌ0.11 Billion 21.71% Jersey
-โ‚ฌ0.26 Billion 179.79%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ12.05 Million-86.67%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ70.19 Million-22.31%๐Ÿ‡ฌ๐Ÿ‡ง UK